Skip to main content
Premium Trial:

Request an Annual Quote

BC Platforms, Nexus Partner on Genome Data Management, Analysis

NEW YORK (GenomeWeb) – BC Platforms announced today that it has signed a deal to combine its genomic data management platform with Nexus Personalized Health Technologies' genomic data analysis and integration technologies.

Specific terms of the arrangement were not disclosed.

Nexus, a part of the Swiss Federal Institute of Technology in Zurich, "is committed to integrating genomic data alongside clinical data to become a leader in translational research in order to provide the best clinical outcomes for patients," Daniel Stekhoven, head of clinical bioformatics at Nexus, said in a statement. "We are pleased to be working with BC Platforms … to provide joint solutions to tackle current genomic data challenges and practically link those to clinical benefits."

"We now have the tools and technologies for the interpretation of complex proprietary genomic data in combination with publicly available clinical data through local initiatives in Switzerland and internationally," BC Platforms CEO Tero Silvola added in the statement.

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.